Abstract
Objectives: To develop a decision analysis based and computerised clinical guidance programme (CGP) that provides patient specific guidance on the decision whether or not to undergo a prophylactic oophorectomy to reduce the risk of subsequent ovarian cancer and to undertake a preliminary pilot and evaluation.
Subjects: Women who had already agreed to have a hysterectomy who otherwise had no ovarian pathology.
Setting: Oophorectomy decision consultation at the outpatient or pre-admission clinic.
Methods: A CGP was developed with advice from gynaecologists and patient groups, incorporating a set of Markov models within a decision analytical framework to evaluate the benefits of undergoing a prophylactic oophorectomy or not on the basis of quality adjusted life expectancy, life expectancy, and for varying durations of hormone replacement therapy. Sensitivity analysis and preliminary testing of the CGP were undertaken to compare its overall performance with established guidelines and practice. A small convenience sample of women invited to use the CGP were interviewed, the interviews were taped and transcribed, and a thematic analysis was undertaken.
Results: The run time of the programme was 20 minutes, depending on the use of opt outs to default values. The CGP functioned well in preliminary testing. Women were able to use the programme and expressed overall satisfaction with it. Some had reservations about the computerised format and some were surprised at the specificity of the guidance given.
Conclusions: A CGP can be developed for a complex healthcare decision. It can give evidence-based health guidance which can be adjusted to account for individual risk factors and reflects a patient's own values and preferences concerning health outcomes. Future decision aids and support systems need to be developed and evaluated in a way which takes account of the variation in patients' preferences for inclusion in the decision making process.
Full Text
The Full Text of this article is available as a PDF (186.2 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Cher D. J., Miyamoto J., Lenert L. A. Incorporating risk attitude into Markov-process decision models: importance for individual decision making. Med Decis Making. 1997 Jul-Sep;17(3):340–350. doi: 10.1177/0272989X9701700311. [DOI] [PubMed] [Google Scholar]
- Coulter A. Partnerships with patients: the pros and cons of shared clinical decision-making. J Health Serv Res Policy. 1997 Apr;2(2):112–121. doi: 10.1177/135581969700200209. [DOI] [PubMed] [Google Scholar]
- Dolan J. G. Can decision analysis adequately represent clinical problems? J Clin Epidemiol. 1990;43(3):277–284. doi: 10.1016/0895-4356(90)90008-d. [DOI] [PubMed] [Google Scholar]
- Dolan P. Modeling valuations for EuroQol health states. Med Care. 1997 Nov;35(11):1095–1108. doi: 10.1097/00005650-199711000-00002. [DOI] [PubMed] [Google Scholar]
- Dowie J. 'Evidence-based', 'cost-effective' and 'preference-driven' medicine: decision analysis based medical decision making is the pre-requisite. J Health Serv Res Policy. 1996 Apr;1(2):104–113. doi: 10.1177/135581969600100208. [DOI] [PubMed] [Google Scholar]
- Dowie J. The research-practice gap and the role of decision analysis in closing it. Health Care Anal. 1996 Feb;4(1):5–18. doi: 10.1007/BF02251141. [DOI] [PubMed] [Google Scholar]
- Grann V. R., Panageas K. S., Whang W., Antman K. H., Neugut A. I. Decision analysis of prophylactic mastectomy and oophorectomy in BRCA1-positive or BRCA2-positive patients. J Clin Oncol. 1998 Mar;16(3):979–985. doi: 10.1200/JCO.1998.16.3.979. [DOI] [PubMed] [Google Scholar]
- Grundsell H., Ekman G., Gullberg B., Johnsson J. E., Larsson G., Lindahl B., Möller T., Tropé C. Some aspects of prophylactic oophorectomy and ovarian carcinoma. Ann Chir Gynaecol. 1981;70(1):36–42. [PubMed] [Google Scholar]
- Jacobs I., Oram D. Prevention of ovarian cancer: a survey of the practice of prophylactic oophorectomy by fellows and members of the Royal College of Obstetricians and Gynaecologists. Br J Obstet Gynaecol. 1989 May;96(5):510–515. doi: 10.1111/j.1471-0528.1989.tb03248.x. [DOI] [PubMed] [Google Scholar]
- Liao L., Jollis J. G., DeLong E. R., Peterson E. D., Morris K. G., Mark D. B. Impact of an interactive video on decision making of patients with ischemic heart disease. J Gen Intern Med. 1996 Jun;11(6):373–376. doi: 10.1007/BF02600051. [DOI] [PubMed] [Google Scholar]
- Schrag D., Kuntz K. M., Garber J. E., Weeks J. C. Decision analysis--effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations. N Engl J Med. 1997 May 15;336(20):1465–1471. doi: 10.1056/NEJM199705153362022. [DOI] [PubMed] [Google Scholar]
- Shepperd S., Coulter A., Farmer A. Using interactive videos in general practice to inform patients about treatment choices: a pilot study. Fam Pract. 1995 Dec;12(4):443–447. doi: 10.1093/fampra/12.4.443. [DOI] [PubMed] [Google Scholar]
- Sightler S. E., Boike G. M., Estape R. E., Averette H. E. Ovarian cancer in women with prior hysterectomy: a 14-year experience at the University of Miami. Obstet Gynecol. 1991 Oct;78(4):681–684. [PubMed] [Google Scholar]
- Sonnenberg F. A., Beck J. R. Markov models in medical decision making: a practical guide. Med Decis Making. 1993 Oct-Dec;13(4):322–338. doi: 10.1177/0272989X9301300409. [DOI] [PubMed] [Google Scholar]
- Speroff T., Dawson N. V., Speroff L., Haber R. J. A risk-benefit analysis of elective bilateral oophorectomy: effect of changes in compliance with estrogen therapy on outcome. Am J Obstet Gynecol. 1991 Jan;164(1 Pt 1):165–174. doi: 10.1016/0002-9378(91)90649-c. [DOI] [PubMed] [Google Scholar]
- Todd C. J., Freeman C. J., Camilleri-Ferrante C., Palmer C. R., Hyder A., Laxton C. E., Parker M. J., Payne B. V., Rushton N. Differences in mortality after fracture of hip: the east Anglian audit. BMJ. 1995 Apr 8;310(6984):904–908. doi: 10.1136/bmj.310.6984.904. [DOI] [PMC free article] [PubMed] [Google Scholar]